Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001179110-19-011013

Options or other derivatives

  • CHIEF EXECUTIVE OFFICER acquired 68,837 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
TABUTEAU HERRIOT CHIEF EXECUTIVE OFFICER 2019-10-10 Grant or award · Employee Stock Option (Right to Buy) +68,837 68,837 D
Loading xslF345X03/edgar.xml…